Grünenthal agreed to acquire the European rights (excluding Spain and the UK) to AstraZeneca’s Crestor (rosuvastatin) and its associated brands for a total consideration of up to $350 million.

Vitas Healthcare chose Greater Than One (GTO) Group as agency of record to support the hospice company’s transformative focus on brand equity, improved efficiency and enhanced return on investment from its marketing initiatives.

PharmaLive talked to Conran Design Group Managing Director Christina Falzano about her experiences working with tech companies’ expansion into the health, wellness and pharma spaces in driving changes in the healthcare industry – especially in how they reposition post-COVID.

Many brands have yet to catch up to the Web Content Accessibility Guidelines (WCAG), for digital inclusion and accessibility for all users.

Huntsworth, an international healthcare and communications group, announced an agreement to acquire Nucleus Global, one of the world’s largest medical specialist communications groups.

Calcium announced the additions of Lynn Nezin, PhD, and Lauren Lazar, MD, to the full-service, independent healthcare marketing agency’s strategic services team.

Eli Lilly, Johnson & Johnson and GlaxoSmithKline headline the second annual edition of the Outcomes Creativity Index (OCI), a ranking of pharmaceutical companies and prescription brands according to creativity and innovation. The OCI is an aggregate score-based creative achievement encompassing results from eight leading U.S. and international healthcare awards shows that are tabulated to rank the top 10 pharmaceutical companies and top 10 prescription brands. 

As pharmaceutical marketing benefits from soaring advances in data availability and data analyses techniques, brand marketers are called upon to select data and analytics partners. Linda von Rosenvinge, Cross-Disciplined Strategist for Greater Than One (GTO), recommends strategy centers on two towering criteria for these decisions: imagination and agility.

After attending several virtual scientific conferences since the start of the COVID-19 lockdown, TBWA\WorldHealth explores which practices should stay, which ones will need to come back, and how pharmaceutical brands can stand out in this medium.

Fernando Fernandez, Managing Director of FCB Health Network’s BX – Brand Experience Design Group, talked to Med Ad News about how COVID-19 has changed the way people interact with brands, how branding innovations such as audio and motion identities are making their way to pharma, and other topics.